Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion

被引：19

作者：

Lowe, FC

Batista, J

Berges, R

Chartier-Kastler, E

Conti, G

Desgrandchamps, F

Dreikorn, K

O'Leary, M

Perez, M

Speakman, M

Trachtenberg, J

Tubaro, A

Meesen, B

Smets, L

Stoevelaar, H

机构：

[1] St Lukes Roosevelt Hosp, New York, NY USA

[2] Fdn Puigvert CM Teknon, Barcelona, Spain

[3] PAN Klin Neumarkt, Cologne, Germany

[4] GH Pitie Salpetriere, Paris, France

[5] Osped S Anna Como, Como, Italy

[6] CHU St Louis, Paris, France

[7] Zent Krankenhaus St Juergenstr, Bremen, Germany

[8] Brigham & Womens Hosp, Boston, MA 02115 USA

[9] Med Sci Univ, Sao Paulo Santa Casa Hosp, Sao Paulo, Brazil

[10] Taunton & Somerset Hosp, Taunton, Somerset, England

[11] Univ Toronto, Toronto, ON, Canada

[12] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[13] Univ Roma La Sapienza, Sant Andrea Hosp, Rome, Italy

[14] Ismar Healthcare, Lier, Belgium

[15] Erasmus Univ, Med Ctr, Rotterdam, Netherlands

来源：

PROSTATE CANCER AND PROSTATIC DISEASES | 2005年 / 8卷 / 03期

关键词：

lower urinary tract symptoms; benign prostatic hyperplasia; disease progression; risk factors;

D O I：

10.1038/sj.pcan.4500806

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.

引用

页码：206 / 209

页数：4

共 14 条

[1]

Brook R H, 1986, Int J Technol Assess Health Care, V2, P53

[2] The urologist view of BPH progression: Results of an international survey [J].

Djavan, B ;

Nickel, JC ;

de la Rosette, J ;

Abrams, P .

EUROPEAN UROLOGY, 2002, 41 (05) :490-496

[3] Natural history of prostatism: Risk factors for acute urinary retention [J].

Jacobsen, SJ ;

Jacobson, DJ ;

Girman, CJ ;

Roberts, RO ;

Rhodes, T ;

Guess, HA ;

Lieber, MM .

JOURNAL OF UROLOGY, 1997, 158 (02) :481-487

[4] Identifying patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) at risk for progression [J].

Jiménez-Cruz, F .

EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) :6-12

[5]

Kaplan SA, 2003, J UROLOGY, V169, P332

[6]

Lowe F., 2004, European Urology Supplements, V3, P39, DOI 10.1016/S1569-9056(04)90148-0

[7]

McConnell JD, 2003, J UROLOGY, V169, P332

[8] The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia [J].

McConnell, JD ;

Bruskewitz, R ;

Walsh, P ;

Andriole, G ;

Lieber, M ;

Holtgrewe, HL ;

Albertsen, P ;

Roehrborn, CG ;

Nickel, JC ;

Wang, DZ ;

Taylor, AM ;

Waldstreicher, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (09) :557-563

[9] The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia [J].

McConnell, JD ;

Roehrborn, CG ;

Bautista, OM ;

Andriole, GL ;

Dixon, CM ;

Kusek, JW ;

Lepor, H ;

McVary, KT ;

Nyberg, LM ;

Clarke, HS ;

Crawford, ED ;

Diokno, A ;

Foley, JP ;

Foster, HE ;

Jacobs, SC ;

Kaplan, SA ;

Kreder, KJ ;

Lieber, MM ;

Lucia, MS ;

Miller, GJ ;

Menon, M ;

Milam, DF ;

Ramsdell, JW ;

Schenkman, NS ;

Slawin, KM ;

Smith, JA ;

Kusek, JW ;

Nyberg, LM ;

Briggs, JP ;

McConnell, JD ;

Crawford, ED ;

Homan, K ;

Donohue, R ;

Parker, D ;

Easterday, K ;

Robertson, K ;

Kaplan, S ;

Wentland, M ;

Hardy, L ;

Roehrborn, C ;

Ahrens, A ;

McConnell, J ;

Hall, D ;

Cutts, D ;

Carter, S ;

Waldrep, K ;

Schenkman, N ;

Sanetrik, K ;

Sihelnik, S ;

Zorn, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) :2387-2398

[10] LUTS, the case is altered [J].

McNicholas, T .

EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (09) :28-35

← 1 2 →